购物车
- 全部删除
- 您的购物车当前为空
ALZ-801 是一种可口服的小分子 β-淀粉样蛋白抗寡聚体和聚集抑制剂,是曲米酸的缬氨酸偶联前药,与母体化合物相比,具有显著改善的 PK 特性和胃肠道耐受性。它是治疗阿尔茨海默病的先进且显著改善的候选药物。
为众多的药物研发团队赋能,
让新药发现更简单!
ALZ-801 是一种可口服的小分子 β-淀粉样蛋白抗寡聚体和聚集抑制剂,是曲米酸的缬氨酸偶联前药,与母体化合物相比,具有显著改善的 PK 特性和胃肠道耐受性。它是治疗阿尔茨海默病的先进且显著改善的候选药物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 398 | 现货 | |
2 mg | ¥ 573 | 现货 | |
5 mg | ¥ 877 | 现货 | |
10 mg | ¥ 1,570 | 现货 | |
25 mg | ¥ 3,480 | 现货 | |
50 mg | ¥ 4,930 | 现货 | |
100 mg | ¥ 7,170 | 现货 |
产品描述 | ALZ-801 is an orally available, valine-conjugated prodrug of tramiprosate. ALZ-801 is an advanced and markedly improved candidate for the treatment of Alzheimer's disease. ALZ-801 is a potent and orally available small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor, a valine-conjugated prodrug of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound. |
体内活性 | ALZ-801与Tramiprosate在雄性CD-1小鼠的血浆和大脑中的比例分别为1.8和3.1[1]。经口给予ALZ-801(单剂量;172 mg/kg)后,在血浆和大脑中的平均AUCt值分别为58,758和5841 ng/ml.h。 |
别名 | Valiltramiprosate |
分子量 | 238.3 |
分子式 | C8H18N2O4S |
CAS No. | 1034190-08-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: < 1 mg/mL (insoluble or slightly soluble) H2O: 20 mg/ml (83.93 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
H2O
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.